OrbiMed Israel BioFund GP Limited Partnership

CIK 1569821 · last filed 2025-10-10

OrbiMed Israel BioFund GP Limited Partnership is a corporate insider who has filed 7 SEC Form 4 insider transactions across 5 companies since 2019. The most recent filing shows the insider bought $40.0M of ACET on Oct 10, 2025. Across all open-market trades the lifetime net is +$54.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.16M

Companies

5

Total Filings

7

Lifetime Open-Market Net

$54.54M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ACET	Director	40,416	$8.20	$331.4K	$56.46M	2	2025-10-10
BiomX Inc. (PHGE.WS) Delisted	Director	3,161,489	$0.01	$27.8K	$496.9K	2	2023-03-17
CMMB	10%+ Owner	577,950	$1.43	$826.5K	-$2.42M	1	2023-01-05
9 METERS BIOPHARMA, INC. (NMTR) Delisted	Director	—	$0.07	—	$0	1	2020-05-04
Eledon Pharmaceuticals, Inc. (NVUS) Delisted	Director	—	—	—	$0	1	2020-02-25

Recent Filings

7 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2025-10-10	ACET	Buy (P)	+40,000,000	$40.00M	EDGAR
2023-06-29	ACET	Buy (P)	+7,875,000	$16.46M	EDGAR
2023-03-17	BiomX Inc. (PHGE.WS) Delisted	Buy (P)	+1,392,000	$341.0K	EDGAR
2023-01-05	CMMB	Sell (S)	−673,800	-$2.42M	EDGAR
2020-05-04	9 METERS BIOPHARMA, INC. (NMTR) Delisted	Grant (A)	—	$0	EDGAR
2020-02-25	Eledon Pharmaceuticals, Inc. (NVUS) Delisted	Sell (S)	—	$0	EDGAR
2019-12-12	BiomX Inc. (PHGE.WS) Delisted	Buy (P)	+17,600	$155.8K	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.